Mark Emalfarb
Founder bij DYADIC INTERNATIONAL, INC.
Vermogen: 8 M $ op 31-03-2024
Actieve functies van Mark Emalfarb
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DYADIC INTERNATIONAL, INC. | Director/Board Member | 01-01-2004 | - |
Chief Executive Officer | 01-06-2008 | - | |
Founder | 01-01-1979 | - | |
President | 01-06-2008 | - | |
Chairman | 01-06-2008 | 01-01-2015 | |
Dyadic International (USA), Inc.
Dyadic International (USA), Inc. BiotechnologyHealth Technology Part of Dyadic International, Inc., Dyadic International (USA), Inc. researches and manufactures genes. The private company is based in Jupiter, FL. The CEO of the company is Mark A. Emalfarb. | Chief Executive Officer | 05-10-2011 | - |
Chairman | 05-10-2011 | - | |
Biotechnology Development for Industry in Pharmaceuticals SLU
Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Director/Board Member | 13-09-2017 | - |
Loopbaan van Mark Emalfarb
Opleiding van Mark Emalfarb
University of Iowa | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Spanje | 2 |
Operationeel
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Chairman | 2 |
Sectoraal
Health Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
DYADIC INTERNATIONAL, INC. | Health Services |
Bedrijven in privébezit | 2 |
---|---|
Dyadic International (USA), Inc.
Dyadic International (USA), Inc. BiotechnologyHealth Technology Part of Dyadic International, Inc., Dyadic International (USA), Inc. researches and manufactures genes. The private company is based in Jupiter, FL. The CEO of the company is Mark A. Emalfarb. | Health Technology |
Biotechnology Development for Industry in Pharmaceuticals SLU
Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Commercial Services |
- Beurs
- Insiders
- Mark Emalfarb
- Ervaring